Malignant neoplasm of endocrine gland

Known as: Malignant neoplasm of endocrine gland, site unspecified, endocrine cancer, Malignant Tumor of Endocrine Gland 
A malignant neoplasm affecting the endocrine glands. Representative examples include thyroid gland carcinoma, parathyroid gland carcinoma, pituitary… (More)
National Institutes of Health

Related topics

Related topics

13 relations

Narrower (5)

Adrenal CancerCarcinoma of Endocrine GlandMalignant neoplasm of pineal glandMalignant tumor of parathyroid gland
(More)
Benign tumor of endocrine glandEndocrine systemEpithelial CellsEpithelium
(More)

Broader (1)

Endocrine Gland Neoplasms

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through…
Acquired tamoxifen resistance remains the major obstacle to breast cancer endocrine therapy. β1-integrin was identified as one of… (More)
Is this relevant?
2012
2012
RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Papillary histotype (PTC) is the… (More)
  • figure 1
  • table 1
  • table 3
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance.
Estrogen receptor α (ERα) expression in breast cancer is predictive of response to endocrine therapy; however, resistance is… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Pancreatic Resection of Isolated Metastases from Nonpancreatic Primary Cancers
The goal of this study is to report the safety and efficacy of pancreatic resection for isolated metastatic cancers from… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2008
Review
2008
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?
The identification of genetic polymorphisms that influence the efficacy and safety of therapies for breast cancer may allow… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2008
Review
2008
Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
The papillary thyroid carcinoma (PTC) is the most frequent endocrine cancer and it is the most common thyroid cancer (85-95… (More)
Is this relevant?
Review
2005
Review
2005
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators
Estrogen receptor (ER), mediating estrogen-signaling stimuli, is a dominant regulator and a key therapeutic target in breast… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2003
Review
2003
Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.
Endocrine therapy, and especially tamoxifen, is the most important systemic treatment of estrogen receptor (ER)-positive breast… (More)
Is this relevant?
Review
1998
Review
1998
Papillary carcinoma of the thyroid gland: treatment based on risk group definition.
  • Blake Cady
  • Surgical oncology clinics of North America
  • 1998
This article outlines the current controversy regarding the extent of treatment of papillary carcinoma of the thyroid. It… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Endoscopic right thyroid lobectomy
Endocrine surgery is well defined by C. Proye: "Attention a ce que vous enlevez, mais attention plus encore a ce que vous laissez… (More)
Is this relevant?